These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report. Moen T; Berger L; Goyer K; Dahl O; Thorsby E Scand J Urol Nephrol Suppl; 1981; 64():30-7. PubMed ID: 6815792 [No Abstract] [Full Text] [Related]
8. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. Waanders MM; Roelen DL; Brand A; Claas FH Transfus Med Rev; 2005 Oct; 19(4):281-7. PubMed ID: 16214017 [TBL] [Abstract][Full Text] [Related]
9. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients. Kerman RH; Van Buren CT; Lewis RM; Kahan BD Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254 [No Abstract] [Full Text] [Related]
10. Probable role of suppressor cells and factors in kidney graft survival. Bensussan A; Klatzmann D; Gluckman JC; Kalil J; Dausset J; Sasportes M Transplant Proc; 1982 Sep; 14(3):584-7. PubMed ID: 6217608 [No Abstract] [Full Text] [Related]
11. Possible mechanism of the beneficial effect of pretransplant blood transfusions on renal allograft survival in man. Singal DP; Joseph S; Szewczuk MR Transplant Proc; 1982 Jun; 14(2):316-8. PubMed ID: 6214059 [No Abstract] [Full Text] [Related]
12. [Current status of human renal allograft and experimental prolongation of renal graft survival]. Hirano T Hokkaido Igaku Zasshi; 1984 Jul; 59(4):389-92. PubMed ID: 6386637 [No Abstract] [Full Text] [Related]
13. Role of HLA DR in renal transplantation. Fotino M; Suthanthiran M N Y State J Med; 1982 Mar; 82(3):327-32. PubMed ID: 7045739 [No Abstract] [Full Text] [Related]
14. The role of immunological parameters in kidney transplantation. Kreisler JM Proc Eur Dial Transplant Assoc; 1983; 19():407-23. PubMed ID: 6348742 [No Abstract] [Full Text] [Related]
15. HLA-DR typing in cadaver kidney donors and recipients in Copenhagen. Thomsen M; Astrup L; Jakobsen B; Morling N; Platz P; Ryder LP; Svejgaard A; Løkkegaard H; Ladefoged J; Thaysen JH Scand J Urol Nephrol Suppl; 1981; 64():79-86. PubMed ID: 6815796 [TBL] [Abstract][Full Text] [Related]
16. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I. Süsal C; Opelz G Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782 [TBL] [Abstract][Full Text] [Related]
17. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft. Middleton D; Martin J; Douglas J; McClelland M Transplantation; 1994 Oct; 58(7):845-8. PubMed ID: 7940720 [TBL] [Abstract][Full Text] [Related]
18. Warm B-cell antibodies and DRw matching: their influence on transplant outcome at a single center. Coxe-Gilliland R; Cross DE Transplant Proc; 1981 Mar; 13(1 Pt 2):945-8. PubMed ID: 7022967 [No Abstract] [Full Text] [Related]
19. Effects of virus types of RBC transfusions on HLA alloimmunization and renal allograft survival. Fuller TC; Delmonico FL; Cosimi AB; Huggins CE; King M; Russell PS Transplant Proc; 1977 Mar; 9(1):117-9. PubMed ID: 325743 [No Abstract] [Full Text] [Related]
20. Impact of blood transfusions and HLA matching on national kidney transplant programs: the first Swedish-Norwegian Study of cyclosporine. Albrechtsen D; Flatmark A; Brynger H; Frödin L; Gäbel H; Groth CG; Lundgren G; Maurer W Transplant Proc; 1988 Jun; 20(3 Suppl 3):257-60. PubMed ID: 3291252 [No Abstract] [Full Text] [Related] [Next] [New Search]